Illumina (ILMN) – Insiders' Blog
-
Legal Pot Business Could Get a Big Jolt on Path to $50B Industry
-
Biotechs Continue to Underperform (IBB)
-
On Sale: Buy This Genomics Powerhouse Cheaper than Lone Pine Capital
-
FBN's Maria Bartiromo to Anchor Live from 33rd Annual J.P. Morgan Healthcare Conference
-
JP Morgan's Top Stock Picks for 2nd-Half of 2013 (FB) (AAPL) (RYL) (more...)
-
Illumina (ILMN) Said to Have Purchase Moleculo, Inc.
-
What Gene Sequencer is Roche (RHHBY) Aiming to Buy? (ILMN) (GENE)
-
Rosetta (ROSG), Complete Genome (GNOM) Shares Surge as Study Finds Genome Sequencing Could Give Early Hints to Disease (GENE)
-
Competition, Spending Cuts Make Illumina (ILMN) One Risky Play - Barron's
-
Investors, Analysts Consider Roche's Bid for Illumina (ILMN) Too Low
-
Shumway's Largest Holdings Could Be Volatile as Fund to Shutter Doors (AAPL, LVS, C, PCLN, BIDU, LYV, more)
-
Lone Pine Capital Likes Illumina's (ILMN) Genetic Code
Back to ILMN Stock Lookup